Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUIZARTINIB vs RABEPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

QUIZARTINIB vs RABEPRAZOLE: Safety Overview

Metric QUIZARTINIB RABEPRAZOLE
Total FAERS Reports 357 11,416
Deaths Reported 61 1,676
Death Rate 17.1% 14.7%
Hospitalizations 121 2,143
Average Patient Age 54.0 yrs 55.7 yrs
% Female Patients 57.9% 71.0%
FDA Approval Date Jul 20, 2023 Apr 24, 2018
Manufacturer Daiichi Sankyo Inc. A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Discontinued